Baillie Gifford & Co’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-744
Closed -$17K 516
2022
Q1
$17K Hold
744
﹤0.01% 387
2021
Q4
$14K Hold
744
﹤0.01% 418
2021
Q3
$10K Hold
744
﹤0.01% 451
2021
Q2
$14K Hold
744
﹤0.01% 400
2021
Q1
$11K Buy
744
+40
+6% +$641 ﹤0.01% 399
2020
Q4
$10K Buy
+704
New +$8.52K ﹤0.01% 391

Other funds holding MDRX

Baillie Gifford & Co's MDRX Position: Q2 2022 in Review

Baillie Gifford & Co sold out of Veradigm Inc. Common Stock (MDRX) in Q2 2022, closing a stake of 744 shares — an estimated $17K sold.

Baillie Gifford & Co first reported a position in MDRX in Q4 2020 and held it in 6 quarters. The position peaked at $17K in Q1 2022. 247 funds tracked by Wall St. Rank hold MDRX as of Q2 2022.

  • Baillie Gifford & Co reported no remaining Veradigm Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Baillie Gifford & Co sold 744 Veradigm Inc. Common Stock shares in Q2 2022, an estimated $17K.
  • Baillie Gifford & Co first reported a position in Veradigm Inc. Common Stock in Q4 2020 and held it in 6 quarters.
  • Baillie Gifford & Co's Veradigm Inc. Common Stock position peaked at $17K in Q1 2022.
  • 247 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q2 2022.

Based on Baillie Gifford & Co's 13F filing for Q2 2022, filed 8 Aug 2022.